NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE223586 Query DataSets for GSE223586
Status Public on Feb 23, 2024
Title Inhibition of ERK 1/2 pathway downregulates YAP1/TAZ signaling in human cardiomyocytes exposed to hyperglycemic conditions
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Hyperglycemia-mediated cardiac dysfunction is an acute initiator in the development of vascular complications, leading to cardiac fibrosis. To investigate the effects of hyperglycemia-mediated changes in cardiomyocytes, cells were cultured in-vitro under normoglycemic (5 mM or 25 mM D-glucose) and hyperglycemic (5 → 50 mM or 25 → 50 mM D-glucose) conditions, respectively. After 24-hours of hyperglycemic exposure, cells were collected for RNA-sequencing (RNA-seq) studies to further investigate the differentially expressed genes (DEG) related to inflammation and fibrosis in samples cultured under hyperglycemic-in comparison with normoglycemic-conditions. Western Blotting was done to evaluate the protein expression of YAP1/TAZ under hyperglycemia induced stress conditions, as it is known to be involved in fibrotic and vascular inflammatory-mediated conditions. RNA-seq revealed the DEG of multiple targets including matrix metalloproteinases and inflammatory mediators, whose expression was significantly altered in the 5 → 50 mM in comparison with the 25 → 50 mM condition. Western Blotting showed a significant upregulation of the protein expression of the YAP1/TAZ pathway under these conditions as well (5 → 50 mM). To further probe the relationship between the inflammatory extracellular-signal-regulated kinase (ERK 1/2) and its downstream effects on YAP1/TAZ expression we studied the effect of inhibition of the ERK 1/2 signaling cascade in the 5 → 50 mM condition. The application of an ERK 1/2 inhibitor inhibited the expression of the YAP1/TAZ protein in the 5 → 50 mM condition, and this strategy may be useful in preventing and improving hyperglycemia associated cardiovascular damage and inflammation.
 
Overall design Analysis of differentially expressed genes in cardiomyocytes cultured in hyperglycemic conditions of 25–50 mM and 5–50 mM glucose in comparison with their respective (25 mM and 5 mM) controls. Each sample has a technical replicate.
 
Contributor(s) Joddar B, Loyola CD, Ramirez SP, Muruganandham A, Singh I
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jan 24, 2023
Last update date Feb 23, 2024
Contact name Irtisha Singh
E-mail(s) isingh@tamu.edu
Phone 9794360856
Organization name Texas A&M University Health Science Center
Department Cell Biology and Genetics
Street address 8447 Riverside Pkwy
City Bryan
State/province Texas
ZIP/Postal code 77807
Country USA
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (8)
GSM6965025 CM25_REP1
GSM6965026 CM25_REP3
GSM6965027 CM25_50_REP2
Relations
BioProject PRJNA926927

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE223586_rpkm_cm25_50.txt.gz 610.1 Kb (ftp)(http) TXT
GSE223586_rpkm_cm5_50.txt.gz 626.3 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap